Sudden death due to troponin T mutations

Journal of the American College of Cardiology

Volumn 29, Issue 3, 1997, Pages 549-555

  Moolman, Johanna C ^a   Corfield, Valerie A ^a   Posen, Berthold ^b   Ngumbela, Kholiswa ^a   Seidman, Christine ^c   Brink, Paul A ^b   Watkins, Hugh ^c,d  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAM; EPIDEMIOLOGY; GENE MUTATION; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH;

BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; DEATH, SUDDEN, CARDIAC; GENOTYPE; HUMANS; MUTATION; PEDIGREE; PHENOTYPE; PROGNOSIS; SURVIVAL ANALYSIS; TROPONIN; TROPONIN T;

EID: 0031052924     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00530-X     Document Type: Article

References (26)

1. Goldstein S, Bayés-de-Luna A, Soldevila JG, editors. Sudden Cardiac Death. Armonk (NY): Futura, 1994:71.
2. Maron BJ, Epstein SE, Roberts WC. Causes of sudden death in competitive athletes. J Am Coll Cardiol 1986;7:204-14.
3. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med 1996;334:1039-44.
4. McKenna WJ, Watkins H. Hypertrophic cardiomyopathy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic Basis of Inherited Disease. 7th ed. New York: McGraw-Hill, 1995:4253-4.
5. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-9, 844-52.
6. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47: 532-8.
7. Maron BJ, Roberts WC, Epstein SE. Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982;65:1388-94.
8. Newman H, Sugrue D, Oakley CM, Goodwin JF, McKenna WJ. Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study. J Am Coll Cardiol 1985;5:1064-74.
9. Schwartz K, Carrier L, Guicheney P, Komadja M. Molecular basis of familial cardomyopathies. Circulation 1995;91:532-40.
10. Watkins H, McKenna WJ, Thierfelder L, et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-64.
11. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature Genet 1995;11:434-7.
12. Bonne G, Carrier L, Bercovici J, et al. A splice acceptor site mutation in the cardiac myosin binding protein-C gene causes familial hypertrophic cardiomyopathy. Nature Genet 1995;11:438-40.
13. Posen BM, Moolman JC, Corfield VA, Brink PA. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac β-myosin heavy chain gene mutations. Br Heart J 1995;74:40-6.
14. Watkins H, Rosenzweig A, Hwang D-S, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992;326:1108-14.
15. Roberts R. Molecular genetics: therapy or terror [editorial]. Circulation 1994;89:449-502.
16. Moolman JC, Ferreira A, Hirschfield W, Hunter J, Corfield VA, Brink PA. Genetic studies of the cardiac myosin heavy chain gene locus in South African families with hypertrophic cardiomyopathy - evidence for genetic heterogeneity. Cardiovasc J Southern Africa 1994;5:6-11.
17. Corfield VA, Moolman JC, Martell R, Brink PA. Polymerase chain reaction-based detection of MN blood-group specific sequences in the human genome. Transfusion 1993;33:119-24.
18. Mesnard L, Samson F, Espinasse I, Durand J, Neveux J-Y, Mercadier J-J. Molecular cloning and developmental expression of human cardiac troponin T. FEBS Lett 1993;328:139-44.
19. Thierfelder L, Watkins H, MacRae C, et al. α-Tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994;77:701-12.
20. Cooper DN, Krawczak M. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet 1990;85:55-74.
21. Anan R, Greve G, Thierfelder L, et al. Prognostic implications of novel β-cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994;93:280-5.
22. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein N. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Nat Acad Sci 1995;25:3864-8.
23. Watkins H, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. Hum Mol Genet 1995;4:1721-7.
24. Moolman JC, Brink PA, Corfield VA. Identification of a new missense mutation at Arg 403, a CpG mutation hotspot, in exon 13 of the β-myosin heavy chain gene in hypertrophic cardiomyopathy. Hum Mol Genet 1993;2: 1731-2.
25. Dausse E, Komadja M, Fetler L. Familial hypertrophic cardiomyopathy: microsatellite haplotyping and identification of a hotspot for mutations in the β-myosin heavy chain gene. J Clin Invest 1993;92:2807-13.
26. Marian AJ, Mares A, Kelly DP, et al. Sudden cardiac death in hypertrophic cardiomyopathy variability in phenotypic expression of β-myosin heavy chain mutations. Eur Heart J 1995;16:368-76.